Pure Global

Product - Vietnam Registration 240000002/PCBB-AG

Access comprehensive regulatory information for Product in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loại B medical device is registered under number 240000002/PCBB-AG and manufactured by CPC1 Pharmaceutical Corporation, Hanoi. The authorized representative in Vietnam is ĐỊA ĐIỂM KINH DOANH - CÔNG TY CỔ PHẦN UPHARMA - NHÀ THUỐC UPHARMA SỐ 72.

This page provides complete technical specifications, regulatory compliance details, 5 companies making similar products including MetaSystems Probes GmbH, Bio-Rad, and 5 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
5 Competitors
5 Recent Registrations
240000002/PCBB-AG
Registration Details
Vietnam MOH Registration: 240000002/PCBB-AG
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Product
VN: Sản phẩm
Gravia sup 200 mg
Risk Class TBYT Loại B

Registration Details

240000002/PCBB-AG

000.00.15.H01-240930-0002

TCCS-45B:2022/CPC1HN

Company Information

Công ty Cổ phần dược phẩm CPC1 Hà Nội

Technical Details

It helps to treat cases of vaginal and vulvar candidiasis (usually caused by Candida albicans), trichomoniasis, or other infections sensitive to Clotrimazol, as evidenced by the following symptoms: vaginal and vulvar redness, swelling, burning sensation during urination or sexual intercourse, and white, cheese-like vaginal discharge. The suppository is intended for use in adults and children aged 12 and above.

Dates and Status

Nov 18, 2024